Metraipolis › archive › dc_c4dd72a66cd8

Baseline Systemic Inflammation Response Index and Clinical Outcomes in Heavily Pretreated Platinum-Resistant Ovarian Cancer Treated with Pembrolizumab… — Europe PMC PMID:42794873

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42794873
DOI
10.3390/cancers18182905
License (as archived)
solo-consultazione
Archived
2026-10-15T22:38:54.765Z
SHA-256 of the archived text
a53a32ca7c2af087a70dfb992d52a1dabd36e90c16c60773d1955dcae441237d
Stable URL of this page
https://metraipolis.com/documento/dc_c4dd72a66cd8

How to cite

Baseline Systemic Inflammation Response Index and Clinical Outcomes in Heavily Pretreated Platinum-Resistant Ovarian Cancer Treated with Pembrolizumab… — Europe PMC PMID:42794873 — Europe PMC (en), https://europepmc.org/article/MED/42794873 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c4dd72a66cd8 (Metraipolis archive dc_c4dd72a66cd8, sha256 a53a32ca7c2af087a70dfb992d52a1dabd36e90c16c60773d1955dcae441237d)
BibTeX
@misc{dcc4dd72a66cd8,
  title = {Baseline Systemic Inflammation Response Index and Clinical Outcomes in Heavily Pretreated Platinum-Resistant Ovarian Cancer Treated with Pembrolizumab… — Europe PMC PMID:42794873},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794873},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c4dd72a66cd8; sha256 a53a32ca7c2af087a70dfb992d52a1dabd36e90c16c60773d1955dcae441237d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794873. Agents can read the archived copy with the MCP tool read_document.